Agile and adaptable infrastructure to work with partners
We partner in many different ways – licensing or acquisition and special purpose vehicle (SPV)
€419 million net product sales in 2019
Our positive performance in 2019 allows us to reinvest in medicines for the future
Multiple specialist therapy areas
Gastroenterology, hepatology and more
One Norgine approach and infrastructure. Over 1,500 people
We believe that all of our employees contribute to our future success as a company